HomeCompareES vs LLY

ES vs LLY: Dividend Comparison 2026

ES yields 4.45% · LLY yields 0.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LLY wins by $1.44M in total portfolio value· pulled ahead in Year 7
10 years
ES
ES
● Live price
4.45%
Share price
$68.41
Annual div
$3.05
5Y div CAGR
33.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.4K
Annual income
$29,915.45
Full ES calculator →
LLY
LLY
● Live price
0.70%
Share price
$886.67
Annual div
$6.23
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.54M
Annual income
$1,207,534.19
Full LLY calculator →

Portfolio growth — ES vs LLY

📍 LLY pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESLLY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ES + LLY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ES pays
LLY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ES
Annual income on $10K today (after 15% tax)
$378.34/yr
After 10yr DRIP, annual income (after tax)
$25,428.13/yr
LLY
Annual income on $10K today (after 15% tax)
$59.72/yr
After 10yr DRIP, annual income (after tax)
$1,026,404.06/yr
At 15% tax rate, LLY beats the other by $1,000,975.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ES + LLY for your $10,000?

ES: 50%LLY: 50%
100% LLY50/50100% ES
Portfolio after 10yr
$820.0K
Annual income
$618,724.82/yr
Blended yield
75.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on LLY right now

ES
Analyst Ratings
11
Buy
14
Hold
4
Sell
Consensus: Hold
Price Target
$73.14
+6.9% upside vs current
Range: $60.00 — $80.00
Altman Z
0.7
Piotroski
5/9
LLY
Analyst Ratings
33
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$1,243.95
+40.3% upside vs current
Range: $985.00 — $1,350.00
Altman Z
7.7
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ES buys
0
LLY buys
0
No recent congressional trades found for ES or LLY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESLLY
Forward yield4.45%0.70%
Annual dividend / share$3.05$6.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.7%100%
Portfolio after 10y$102.4K$1.54M
Annual income after 10y$29,915.45$1,207,534.19
Total dividends collected$73.7K$1.49M
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$73.14$1,243.95

Year-by-year: ES vs LLY ($10,000, DRIP)

YearES PortfolioES Income/yrLLY PortfolioLLY Income/yrGap
1$11,295$595.11$10,841$140.53+$454.00ES
2$12,926$839.92$11,884$284.74+$1.0KES
3$15,032$1,201.01$13,299$583.47+$1.7KES
4$17,829$1,745.20$15,451$1,220.47+$2.4KES
5$21,663$2,586.51$19,183$2,650.30+$2.5KES
6$27,107$3,927.03$26,676$6,150.32+$431.00ES
7← crossover$35,144$6,139.95$44,530$15,986.45$9.4KLLY
8$47,551$9,946.91$97,527$49,880.25$50.0KLLY
9$67,697$16,816.79$308,551$204,197.51$240.9KLLY
10$102,351$29,915.45$1,537,684$1,207,534.19$1.44MLLY

ES vs LLY: Complete Analysis 2026

ESStock

Eversource Energy, a public utility holding company, engages in the energy delivery business. The company operates through Electric Distribution, Electric Transmission, Natural Gas Distribution, and Water Distribution segments. It is involved in the transmission and distribution of electricity; solar power facilities; and distribution of natural gas. The company operates regulated water utilities that provide water services to approximately 226,000 customers. It serves residential, commercial, industrial, municipal and fire protection, and other customers in Connecticut, Massachusetts, and New Hampshire. The company was formerly known as Northeast Utilities and changed its name to Eversource Energy in April 2015. Eversource Energy is based in Springfield, Massachusetts.

Full ES Calculator →

LLYHealthcare

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Full LLY Calculator →
📬

Get this ES vs LLY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ES vs SCHDES vs JEPIES vs OES vs KOES vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.